Prognostic groups for management of clinically localized Hodgkin’s disease

  • S. B. Sutcliffe
  • M. K. Gospodarowicz
  • D. E. Bergsagel
  • R. S. Bush
  • R. Chua
  • T. C. Brown
  • D. F. Rideout
Part of the Developments in Oncology book series (DION, volume 32)

Abstract

Radiation therapy has conventionally been applied following surgical staging of Hodgkin’s disease. However, the risk of occult upper abdominal disease and the need for upper abdominal radiation despite a negative laparotomy are now well recognized. Furthermore, factors other than anatomical stage are increasingly influencing therapeutic choice. The present analysis defines a treatment approach for patients receiving radical irradiation for Clinical Stages (CS) I and II Hodgkin’s disease, based upon an analysis of outcome for the period 1968–1977.

Keywords

Lymphoma Oncol Lewin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lukes RJ and Butler JJ (1966). The pathology of nomenclature of Hodgkin’s disease. Cancer Res 26: 1063–1081.PubMedGoogle Scholar
  2. 2.
    Rosenberg SA (1966). Report of the Committee on the Staging of Hodgkin’s Disease. Cancer Res 26: 1310.Google Scholar
  3. 3.
    Peto R, Pike MC, Armitage P et al. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Brit J Cancer 35: 1–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Leung PMK, Van Dyk J and Robins J (1974). A method of large irregular field compensation. Brit J Radiol 47: 805–810.PubMedCrossRefGoogle Scholar
  5. 5.
    Mauch PM, Lewin A and Hellman S (1982). Role of radiation therapy in the treatment of Stage I-II Hodgkin’s disease. In: Rosenberg SA and Kaplan HS (Eds.). Malignant Lymphomas: Etiology, Immunology, Pathology, Treatment, pp. 453–463. Academic Press, New York, N.Y.Google Scholar
  6. 6.
    Hoppe RT, Coleman CN, Cox RS, et al. (1982). The management of Stage I-II Hodgkin’s disease with irradiation alone or combined modality therapy: The Stanford Experience. Blood 59: 455–465.PubMedGoogle Scholar
  7. 7.
    Hoppe RT, Cox RS, Rosenberg SA and Kaplan HS (1982). Prognostic factors in pathologic stage III Hodgkin’s disease. Cancer Treat Rep 66: 743–749.PubMedGoogle Scholar
  8. 8.
    DeVita VT Jr, Simon RM, Hubbard SM et al. (1980). Curability of advanced Hodgkin’s disease with chemotherapy. Ann Intern Med 92: 587–595.PubMedGoogle Scholar
  9. 9.
    Lee CKK, Bloomfield CD, Goldman AI, et al. (1981). The therapeutic utility of lung irradiation for Hodgkin’s disease patients with large mediastinal masses. Int J Radiat Oncol Biol Phys 7: 151–154.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1985

Authors and Affiliations

  • S. B. Sutcliffe
    • 1
  • M. K. Gospodarowicz
    • 1
  • D. E. Bergsagel
    • 1
  • R. S. Bush
    • 1
  • R. Chua
    • 1
  • T. C. Brown
    • 1
  • D. F. Rideout
    • 1
  1. 1.The Princess Margaret HospitalTorontoCanada

Personalised recommendations